Drug repurposing offers an efficient strategy to identify new uses for existing medications, accelerating the transition from research to clinical practice. In this context, observational studies can serve as a valuable alternative to clinical trials, although they face challenges in dis-entangling causal relationships from mere correlations. For this reason, this study proposes leveraging observational data for drug repurposing by integrating causal inference within a functional data analysis frame-work. Using UK Biobank data, we investigate the potential of repurpos-ing metformin, a widely used and cost-effective diabetes medication, for treating kidney disease. Moving beyond traditional cross-sectional anal-yses, we focus on functional outcomes derived from longitudinal mea-surements instead of single-timepoint diagnoses. We use a weighting approach to control for measurable confounding factors and construct a pseudo-population to estimate the causal association of the treatment on functional outcomes, applying a weighted functional-on-scalar mod-elling approach. Our findings suggest a positive effect of metformin on kidney function, supporting its potential role as a renoprotective factor and providing a foundation for future clinical trials. Our methodolog-ical approach enables robust causal effect estimation with longitudinal observational data, addressing limitations of traditional study designs and enhancing the ability to infer causal treatment effects on functional outcomes.

Fostering Drug Repurposing Using Observational Data by Integrating Functional Data Analysis and Causal Inference

Nicole Fontana;Piercesare Secchi;Francesca Ieva
2025-01-01

Abstract

Drug repurposing offers an efficient strategy to identify new uses for existing medications, accelerating the transition from research to clinical practice. In this context, observational studies can serve as a valuable alternative to clinical trials, although they face challenges in dis-entangling causal relationships from mere correlations. For this reason, this study proposes leveraging observational data for drug repurposing by integrating causal inference within a functional data analysis frame-work. Using UK Biobank data, we investigate the potential of repurpos-ing metformin, a widely used and cost-effective diabetes medication, for treating kidney disease. Moving beyond traditional cross-sectional anal-yses, we focus on functional outcomes derived from longitudinal mea-surements instead of single-timepoint diagnoses. We use a weighting approach to control for measurable confounding factors and construct a pseudo-population to estimate the causal association of the treatment on functional outcomes, applying a weighted functional-on-scalar mod-elling approach. Our findings suggest a positive effect of metformin on kidney function, supporting its potential role as a renoprotective factor and providing a foundation for future clinical trials. Our methodolog-ical approach enables robust causal effect estimation with longitudinal observational data, addressing limitations of traditional study designs and enhancing the ability to infer causal treatment effects on functional outcomes.
2025
Statistics for Innovation III. SIS 2025
978-3-031-95994-3
9783031959950
causal inference, functional data analysis, drug repurposing, observational data
File in questo prodotto:
File Dimensione Formato  
Fontana et al.pdf

accesso aperto

: Publisher’s version
Dimensione 559.4 kB
Formato Adobe PDF
559.4 kB Adobe PDF Visualizza/Apri
SIS_2025.pdf

Accesso riservato

Descrizione: Fontana_SIS_2025
: Post-Print (DRAFT o Author’s Accepted Manuscript-AAM)
Dimensione 218.26 kB
Formato Adobe PDF
218.26 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11311/1297910
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact